ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

A Survey of Lung Transplant Recipient Attitudes and Beliefs on Accepting an Organ That Was Positive for Hepatitis C Virus

S. S. Humar1, N. Pinzon1, M. Cypel1, S. Abbey2

1University Health Network, Transplant Center, Toronto, ON, Canada, 2University Health Network, Center for Mental Health, Toronto, ON, Canada

Meeting: 2020 American Transplant Congress

Abstract number: 390

Keywords: Lung transplantation, Psychosocial

Session Information

Session Name: Lung: Let's Start at the Beginning: Pre-Transplant Decision Making and Access to Lung Donors

Session Type: Oral Abstract Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:45pm

 Presentation Time: 3:15pm-3:27pm

Location: Virtual

*Purpose: Recent data show that organs from donors who are HCV positive (+ve) can be safely transplanted into HCV negative recipients. We conducted a survey of lung transplant recipients and candidates who had consented to receive an HCV+ve organ. The purpose was to determine factors influencing the decision to accept HCV+ve organs and the psychosocial impacts in the post-transplant period.

*Methods: Adult lung transplant patients or candidates who had consented to receive an HCV+ve organ completed a survey consisting of 55 questions including multiple choice, a 5-point Likert scale, and free-text answers, with categories related to demographics, pre-transplant attitudes towards HCV+ve organs, decisions around acceptance, and post-transplant impacts of receiving HCV+ve organs.

*Results: A total of 67 HCV-negative lung transplant recipients or candidates who had consented to receive HCV+ve organs were enrolled in the study (median age 27-76 years; 61% male). 24/67 (36%) received lungs that were HCV+ve, 36 (54%) received HCV negative lungs, and 7(10%) were still on the waiting list at the time of survey. Prior to transplant 50/67 (75%) patients felt it was either completely safe or very safe to accept an HCV+ve organ. This was also consistent with both their family’s attitude and their primary physician’s attitude. Although 22/67 (33%) saw themselves as people who never or rarely took risks, they still made the decision to accept an HCV+ve organ. Common themes in the pre-transplant setting were desperation, perception of having ‘no choice’, and increasing severity of symptoms. In the subset of patients that were offered and accepted an HCV+ve organ (n=24), 33% were somewhat or very concerned about contracting HCV, and only 12.5% expressed having second thoughts about accepting the organ. Post-transplant, the majority (87.5%) never felt any anxiety about HCV. Most (83%) reported no impact from HCV on their overall well-being after transplantation. Generally, patients were not concerned about the risk of transmission to family members sufficiently enough to alter any of their behaviours after receiving the transplant. Perception of treatment tolerability and ease was highly favourable in most patients. 87.5% of patients said they would still have accepted an HCV+ve organ if they had to do it over again, and had similar advice for others. For those who consented to HCV+ve organs but received an HCV negative organ, 53% of patients were somewhat or very relieved, but most (89%) were likely or very likely to accept an HCV organ if needed in the future.

*Conclusions: Our survey provides unique insights into acceptance of HCV positive organs. Overall, patients found the experience to be very acceptable and positive. Use of these organs has minimal detrimental psychosocial impacts on lung transplant patients.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Humar SS, Pinzon N, Cypel M, Abbey S. A Survey of Lung Transplant Recipient Attitudes and Beliefs on Accepting an Organ That Was Positive for Hepatitis C Virus [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/a-survey-of-lung-transplant-recipient-attitudes-and-beliefs-on-accepting-an-organ-that-was-positive-for-hepatitis-c-virus/. Accessed June 6, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences